Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €1.65 | €4.63 | 181.204% |
| Henry Schein Inc. | 15 | 1 | 1 | 0 | €62.42 | €76.08 | 21.883% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |
| HCA Holdings Inc. | 42 | 0 | 4 | 0 | €346.60 | €353.98 | 2.128% |
| Halozyme Therapeutics Inc. | 22 | 0 | 1 | 0 | €53.48 | €57.30 | 7.146% |
| GSK plc ADR | 5 | 0 | 0 | 0 | €40.00 | €49.33 | 23.318% |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.38 | - | - |
| Globus Medical A | 1 | 0 | 0 | 0 | €63.00 | - | - |
| Glaukos Corp | 1 | 0 | 0 | 0 | €116.00 | - | - |
| Gilead Sciences Inc | 10 | 0 | 1 | 0 | €72.25 | €84.47 | 16.915% |
| Gerresheimer AG | 3 | 0 | 0 | 0 | €105.50 | - | - |
| Geron Corp. | 16 | 0 | 1 | 0 | €3.94 | €5.54 | 40.541% |
| Galmed Pharmaceuticals Ltd. | 13 | 0 | 1 | 0 | €3.04 | €68.81 | 2163.322% |
| G1 Therapeutics | 19 | 1 | 0 | 0 | €6.46 | €11.09 | 71.659% |
| Fresenius SE & Co. KGaA | 3 | 0 | 0 | 0 | €33.61 | - | - |
| Fresenius Medical Care AG & Co KGaA ADR | 8 | 1 | 0 | 0 | €17.60 | - | - |
| Faron Pharmaceuticals Oy | 2 | 1 | 0 | 0 | €2.60 | €10.00 | 284.615% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €19.22 | €20.00 | 4.058% |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.72 | €6.00 | 61.507% |
| EyePoint Pharmaceuticals Inc. | 20 | 1 | 2 | 0 | €7.25 | €27.83 | 284.088% |
| Exelixis Inc. | 22 | 0 | 1 | 0 | €23.12 | €26.01 | 12.484% |
| Exact Sciences | 18 | 0 | 1 | 0 | €53.25 | €76.01 | 42.749% |
| Evotec SE | 10 | 1 | 8 | 0 | €6.00 | €7.00 | 16.667% |
| Evolus Inc | 12 | 0 | 1 | 0 | €12.80 | €22.65 | 76.983% |
| EssilorLuxottica SA | 3 | 0 | 1 | 0 | €208.10 | €260.00 | 24.940% |